Healthy Lifestyle Lowers Mortality in CKD Patients

May 2013
Renal & Urology News;May2013, Vol. 12 Issue 5, p10
The article reports on the study published in the "Clinical Journal of the American Society of Nephrology" regarding the less likely of patients with chronic kidney disease (CKD) who have the highest healthy lifestyle scores to die than those with the lowest healthy lifestyle scores.


Related Articles

  • Mortality in Chronic Kidney Disease and Mineral Metabolism. Floege, Jürgen; Kronenberg, Florian; Froissart, Marc; Palmer, Suetonia; Craig, Jonathan; Strippoli, Giovanni F. M. // JAMA: Journal of the American Medical Association;7/13/2011, Vol. 306 Issue 2, p159 

    A letter to the editor is presented in response to the article "Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis," by S. C. Palmer and colleagues, in a 2011...

  • What is the Best Path Length for Aortic Pulse Wave Velocity? Preliminary Answer to a Stiff Question. Sharman, James E. // American Journal of Hypertension;Feb2011, Vol. 24 Issue 2, p122 

    In this article, the author discusses the answer to path length for aortic pulse wave velocity. He presents the aortic stiffness which impairs ventricular-vascular interaction, lessens cardiac performance, and a predictor of cardiovascular death rate. Also investigated the three aortic path...

  • Phosphate-Binder Treatment May Lower Mortality.  // Renal & Urology News;Nov2010, Vol. 9 Issue 11, p37 

    The article offers information on the study by Csaba P. Kovesdy which shows that lower mortality rate in men with non-dialysis-dependent chronic kidney disease (CKD) is associated with the phosphate-binder treatment.

  • Haptoglobin genotypes, inflammation status and their associations with hemoglobin levels in stage 4 chronic kidney disease patients with anemia. Mogadam, Reza Alipanah; Ghorbanihaghjo, Amir; Argani, Hassan; Hosseini-Asl, Saied // HealthMed;2013, Vol. 7 Issue 3, p779 

    Background and aims: Anemia and increased inflammation are the main causes of mortality in chronic kidney disease (CKD) patients. This study was designed to explore the probable relationship of hemoglobin (Hb) with serum haptoglobin (HP), its genotypes and inflammation statues in CKD stage 4...

  • Vitamin D Deficiency Increases Death Risk.  // Renal & Urology News;May2011, Vol. 10 Issue 5, p9 

    The article reports that vitamin D deficiency is associated with increased mortality risk among chronic kidney disease (CKD) patients.

  • Cystatin C is correlated with mortality in patients with and without acute kidney injury. Bell, Max; Granath, Fredrik; Mårtensson, Johan; Löfberg, Erland; Ekbom, Anders; Martling, Claes-Roland // Nephrology Dialysis Transplantation;Oct2009, Vol. 24 Issue 10, p3096 

    Background. Recent research has shown cystatin C to predict mortality and cardiovascular morbidity independent of renal function. The aim of this study was to evaluate the prognostic value of cystatin C on mortality in adult general ICU patients with acute kidney injury (AKI). We later expanded...

  • Suggested management of immunocompromized kidney patients suffering from SARS. Man-Chun Chiu, Lesley // Pediatric Nephrology;Dec2003, Vol. 18 Issue 12, p1204 

    The treatment of severe acute respiratory syndrome (SARS) is still empirical and controversial. Herein we report our experience in treating approximately 40 SARS children and adolescents. Treatment of SARS kidney patients is limited. Paediatric nephrologists should be on the alert for SARS in...

  • Variation of hemodialysis related arterial stiffness in patients with end stage renal disease. Condor, Ariana; Buzdugan, Elena; Crişan, Sorin; Pestrea, Cătălin // Human & Veterinary Medicine;Dec2009, Vol. 1 Issue 2, p59 

    Objective: Cardiovascular disease is the leading cause of morbidity and mortality in patients undergoing hemodialysis. Increased arterial stiffness is an independent predictor of cardiovascular mortality in end stage renal disease (ESRD). We hypothesized that the hemodialysis procedure itself,...

  • Effects of Antiplatelet Therapy on Mortality and Cardiovascular and Bleeding Outcomes in Persons With Chronic Kidney Disease. Palmer, Suetonia C.; Micco, Lucia Di; Razavian, Mona; Craig, Jonathan C.; Perkovic, Vlado; Pellegrini, Fabio; Copetti, Massimiliano; Graziano, Giusi; Tognoni, Gianni; Jardine, Meg; Webster, Angela; Nicolucci, Antonio; Zoungas, Sophia; Strippoli, Giovanni F. M. // Annals of Internal Medicine;3/20/2012, Vol. 156 Issue 6, p445 

    Background: Antiplatelet agents are used to prevent cardiovascular events; however, treatment effects may differ in persons with chronic kidney disease (CKD) because atherosclerotic disease is less prevalent, whereas bleeding hazards may be increased in this population. Purpose: To summarize the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics